Jennifer Schranz Nabriva Therapeutics PLC (NBRV) insider trading activity

Jennifer Schranz is Chief Medical Officer of Nabriva Therapeutics plc. Currently has a direct ownership of 39,125 shares of NBRV, which is worth approximately $15,650. The most recent transaction as insider was on Feb 28, 2021, when has been sold 33 shares (Ordinary Shares) at a price of $2.39 per share, resulting in proceeds of $79. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1K

0% 3M change

0% 12M change

Total Value Held $15,650

Jennifer Schranz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2021	SELL Payment of exercise price or tax liability	$79 $2.39 p/Share	33 Reduced 0.08%	39,125 Ordinary Shares
Jan 31 2021	SELL Payment of exercise price or tax liability	$94 $2.62 p/Share	36 Reduced 0.09%	39,158 Ordinary Shares
Jan 29 2021	BUY Grant, award, or other acquisition	-	22,500 Added 36.47%	39,194 Ordinary Shares
Dec 31 2020	SELL Payment of exercise price or tax liability	$73 $2.42 p/Share	30 Reduced 0.18%	16,694 Ordinary Shares
Nov 30 2020	SELL Payment of exercise price or tax liability	$129 $0.43 p/Share	301 Reduced 0.18%	167,240 Ordinary Shares
Oct 31 2020	SELL Payment of exercise price or tax liability	$150 $0.5 p/Share	301 Reduced 0.18%	167,541 Ordinary Shares
Sep 30 2020	SELL Payment of exercise price or tax liability	$160 $0.53 p/Share	301 Reduced 0.18%	167,842 Ordinary Shares

Jennifer Schranz

Chief Medical Officer

King Of Prussia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Value

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV

Account